Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario.

Vu K, Pardhan A, Lakhani N, Metcalfe S, Mozuraitis M, Krzyzanowska M.

J Oncol Pharm Pract. 2020 Mar 2:1078155220907650. doi: 10.1177/1078155220907650. [Epub ahead of print] No abstract available.

PMID:
32122233
2.

ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases.

Kumthekar P, Tang SC, Brenner AJ, Kesari S, Piccioni DE, Anders CK, Carrillo JA, Chalasani P, Kabos P, Puhalla SL, Tkaczuk KHR, Garcia A, Ahluwalia MS, Wefel JS, Lakhani N, Ibrahim NK.

Clin Cancer Res. 2020 Jan 22. pii: clincanres.3258.2019. doi: 10.1158/1078-0432.CCR-19-3258. [Epub ahead of print]

3.

Effect of betaine supplementation on growth performance, nutrient intake and expression of IGF-1 in Karan Fries heifers during thermal stress.

Lakhani P, Kumar P, Alhussien MN, Lakhani N, Grewal S, Vats A.

Theriogenology. 2020 Jan 15;142:433-440. doi: 10.1016/j.theriogenology.2019.10.021. Epub 2019 Oct 23.

PMID:
31711708
4.

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.

Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, Fisher GA, Villalobos V, Prohaska SS, Howard M, Beeram M, Chao MP, Agoram B, Chen JY, Huang J, Axt M, Liu J, Volkmer JP, Majeti R, Weissman IL, Takimoto CH, Supan D, Wakelee HA, Aoki R, Pegram MD, Padda SK.

J Clin Oncol. 2019 Apr 20;37(12):946-953. doi: 10.1200/JCO.18.02018. Epub 2019 Feb 27.

PMID:
30811285
5.

Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania.

Noorani M, Lakhani N.

BMC Pediatr. 2018 Oct 23;18(1):334. doi: 10.1186/s12887-018-1306-5.

6.

Immune status and haemato-biochemical profile of buffalo calves supplemented with phytogenic feed additives rich in tannins, saponins and essential oils.

Lakhani N, Kamra DN, Lakhani P, Alhussien MN.

Trop Anim Health Prod. 2019 Mar;51(3):565-573. doi: 10.1007/s11250-018-1727-z. Epub 2018 Oct 17.

PMID:
30328547
7.

A retrospective analysis of tolerance and outcomes of cutaneous malignant melanoma in patients receiving adjuvant interferon-alpha 2B: a community oncology perspective.

Afzal MZ, Pinnamaneni V, Birendra KC, Davis AT, Koehler TJ, Lakhani N.

J Exp Ther Oncol. 2017 Sep;11(2):91-96.

PMID:
28976130
8.

Developing family medicine in Ethiopia.

Lakhani NA, Nwosu O.

Educ Prim Care. 2017 Nov;28(6):351-352. doi: 10.1080/14739879.2017.1325717. Epub 2017 May 18. No abstract available.

PMID:
28521577
9.

Technology-Enabled Remote Monitoring and Self-Management - Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol.

McGillion M, Yost J, Turner A, Bender D, Scott T, Carroll S, Ritvo P, Peter E, Lamy A, Furze G, Krull K, Dunlop V, Good A, Dvirnik N, Bedini D, Naus F, Pettit S, Henry S, Probst C, Mills J, Gossage E, Travale I, Duquette J, Taberner C, Bhavnani S, Khan JS, Cowan D, Romeril E, Lee J, Colella T, Choinière M, Busse J, Katz J, Victor JC, Hoch J, Isaranuwatchai W, Kaasalainen S, Ladak S, O'Keefe-McCarthy S, Parry M, Sessler DI, Stacey M, Stevens B, Stremler R, Thabane L, Watt-Watson J, Whitlock R, MacDermid JC, Leegaard M, McKelvie R, Hillmer M, Cooper L, Arthur G, Sider K, Oliver S, Boyajian K, Farrow M, Lawton C, Gamble D, Walsh J, Field M, LeFort S, Clyne W, Ricupero M, Poole L, Russell-Wood K, Weber M, McNeil J, Alpert R, Sharpe S, Bhella S, Mohajer D, Ponnambalam S, Lakhani N, Khan R, Liu P, Devereaux PJ.

JMIR Res Protoc. 2016 Aug 1;5(3):e149. doi: 10.2196/resprot.5763.

10.

Interprofessional learning on polypharmacy.

Anderson E, Lakhani N.

Clin Teach. 2016 Aug;13(4):291-7. doi: 10.1111/tct.12485. Epub 2016 Feb 3.

PMID:
26840754
11.

Evidence-Based Cancer Survivorship Activities for Comprehensive Cancer Control.

Underwood JM, Lakhani N, Finifrock D, Pinkerton B, Johnson KL, Mallory SH, Migliore Santiago P, Stewart SL.

Am J Prev Med. 2015 Dec;49(6 Suppl 5):S536-42. doi: 10.1016/j.amepre.2015.08.011.

12.

Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board.

Lane BR, Bissonnette J, Waldherr T, Ritz-Holland D, Chesla D, Cottingham SL, Alberta S, Liu C, Thompson AB, Graveel C, MacKeigan JP, Noyes SL, Smith J, Lakhani N, Steensma MR; Spectrum Health Tumor Sequencing Advisory Board.

J Mol Diagn. 2015 Nov;17(6):695-704. doi: 10.1016/j.jmoldx.2015.07.003. Epub 2015 Aug 30.

13.

Cataracts.

Thompson J, Lakhani N.

Prim Care. 2015 Sep;42(3):409-23. doi: 10.1016/j.pop.2015.05.012. Review.

PMID:
26319346
14.

Necrotizing Fasciitis of the Abdominal Wall Caused by Serratia Marcescens.

Lakhani NA, Narsinghani U, Kumar R.

Infect Dis Rep. 2015 Apr 15;7(2):5774. doi: 10.4081/idr.2015.5774. eCollection 2015 Apr 15.

15.

Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review.

Birendra KC, Afzal MZ, Wentland KA, Hashmi H, Singh S, Ivan E, Lakhani N.

Am J Case Rep. 2015 Jun 5;16:347-52. doi: 10.12659/AJCR.892883. Review.

16.

Progressive left-sided facial swelling and proptosis.

Kumar R, Lakhani NA, Narsinghani U.

Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):95-6. No abstract available.

17.

An evaluation of cancer survivorship activities across national comprehensive cancer control programs.

Underwood JM, Lakhani N, Rohan E, Moore A, Stewart SL.

J Cancer Surviv. 2015 Sep;9(3):554-9. doi: 10.1007/s11764-015-0432-4. Epub 2015 Mar 3.

18.

Association between psoriasis and leisure-time physical activity: findings from the National Health and Nutrition Examination Survey.

Do YK, Lakhani N, Malhotra R, Halstater B, Theng C, Østbye T.

J Dermatol. 2015 Feb;42(2):148-53. doi: 10.1111/1346-8138.12721. Epub 2014 Dec 9.

PMID:
25491719
19.

Total body skin examination for skin cancer screening among U.S. adults from 2000 to 2010.

Lakhani NA, Saraiya M, Thompson TD, King SC, Guy GP Jr.

Prev Med. 2014 Apr;61:75-80. doi: 10.1016/j.ypmed.2014.01.003. Epub 2014 Jan 10.

20.

Could triaging family history of cancer during palliative care enable earlier genetic counseling intervention?

Lakhani NS, Weir J, Allford A, Kai J, Barwell JG.

J Palliat Med. 2013 Nov;16(11):1350-5. doi: 10.1089/jpm.2012.0583. Epub 2013 Sep 24.

21.

A growing abdominal problem.

Kulkarni K, Lakhani N, Cope A, McGrath D.

BMJ. 2013 Aug 5;347:f4547. doi: 10.1136/bmj.f4547. No abstract available.

PMID:
23918608
22.

Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions.

Stewart SL, Lakhani N, Brown PM, Larkin OA, Moore AR, Hayes NS.

J Womens Health (Larchmt). 2013 Aug;22(8):651-7. doi: 10.1089/jwh.2013.4465. Epub 2013 Jul 18. Review.

23.

The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative.

Wiysonge CS, Armah GE, Madhi SA, Were F, Kitaka SB, Akoua-Koffi C, Gresenguet G, Gatheru Z, Maranga PW, Dicko A, Falade AG, Boula AY, Kuit SB, Odusanya OO, Sow PS, Lakhani N, Mpabalwani EM, Tamfum JJ, Hussey GD.

Pan Afr Med J. 2011;8:24. Epub 2011 Mar 14.

24.

Prevalence and predictors of total-body skin examination among US adults: 2005 National Health Interview Survey.

Lakhani NA, Shaw KM, Thompson T, Yaroch AL, Glanz K, Hartman AM, Saraiya M.

J Am Acad Dermatol. 2011 Sep;65(3):645-648. doi: 10.1016/j.jaad.2011.02.028. No abstract available.

PMID:
21839321
25.

E-learning for interprofessional education: a challenging option.

Williams J, Lakhani N.

J Interprof Care. 2010 Mar;24(2):201-3. doi: 10.1080/13561820902921670. No abstract available.

PMID:
19705323
26.

Probable linezolid-induced pancytopenia.

Lakhani N, Thompson W, Bombassaro AM.

Can J Infect Dis Med Microbiol. 2005 Sep;16(5):286-8.

27.

A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Mukherjee A, Huber K, Evans H, Lakhani N, Martin S.

Br J Pharmacol. 2007 Aug;151(8):1167-75. Epub 2007 Jun 18.

28.

Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol.

Lakhani NJ, Sparreboom A, Xu X, Veenstra TD, Venitz J, Dahut WL, Figg WD.

J Pharm Sci. 2007 Jul;96(7):1821-31.

PMID:
17252610
29.

Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol.

Lakhani N, Sparreboom A, Venitz J, Dahut WL, Figg WD.

Anticancer Drugs. 2006 Sep;17(8):977-83.

PMID:
16940808
30.

Training for crisis resolution home treatment teams.

Lakhani N.

Nurs Times. 2006 May 2-8;102(18):19-20.

PMID:
16703986
31.

Could contracts make secure foundations for early entrants?

Lakhani N.

Health Serv J. 2006 Apr 13;116(6001):14-5. No abstract available.

PMID:
16673569
32.

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.

Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Nguyen D, Yang SX, Steinberg SM, Venitz J, Sparreboom A, Figg WD.

Cancer Biol Ther. 2006 Jan;5(1):22-7. Epub 2006 Jan 22.

PMID:
16357512
33.

Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry.

Lakhani NJ, Lepper ER, Sparreboom A, Dahut WL, Venitz J, Figg WD.

Rapid Commun Mass Spectrom. 2005;19(9):1176-82.

PMID:
15818726
34.

Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection.

Lakhani NJ, Sparreboom A, Dahut WL, Venitz J, Figg WD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):289-93.

PMID:
15171941
35.

Pharmacogenetics of estrogen metabolism and transport in relation to cancer.

Lakhani NJ, Venitz J, Figg WD, Sparreboom A.

Curr Drug Metab. 2003 Dec;4(6):505-13. Review.

PMID:
14683478
36.

A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.

Hamilton M, Dahut W, Brawley O, Davis P, Wells-Jones T, Kohler D, Duray P, Liewehr DJ, Lakhani N, Steinberg SM, Figg WD, Reed E.

Acta Oncol. 2003;42(3):195-201.

PMID:
12852695
37.

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.

Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB.

J Clin Oncol. 2003 Jun 15;21(12):2299-304.

PMID:
12805330
38.

Prevalence and correlates of diarrhea.

Shah SM, Yousafzai M, Lakhani NB, Chotani RA, Nowshad G.

Indian J Pediatr. 2003 Mar;70(3):207-11.

PMID:
12785290
39.

Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer.

Horne MK 3rd, Figg WD, Arlen P, Gulley J, Parker C, Lakhani N, Parnes H, Dahut WL.

Pharmacotherapy. 2003 Mar;23(3):315-8.

PMID:
12627929
40.

2-Methoxyestradiol, a promising anticancer agent.

Lakhani NJ, Sarkar MA, Venitz J, Figg WD.

Pharmacotherapy. 2003 Feb;23(2):165-72. Review.

PMID:
12587805
41.

Antiangiogenesis therapeutic strategies in prostate cancer.

Macpherson GR, Ng SS, Lakhani NJ, Price DK, Venitz J, Figg WD.

Cancer Metastasis Rev. 2002;21(1):93-106. Review.

PMID:
12400998
42.
43.

Alcohol use amongst community-dwelling elderly people: a review of the literature.

Lakhani N.

J Adv Nurs. 1997 Jun;25(6):1227-32. Review.

PMID:
9181421

Supplemental Content

Loading ...
Support Center